Skip to content
Screener

Stryker SYK Total Equity

Discontinued — last reported Q4 '18

Total Equity at other companies

Baxter International logo
Baxter InternationalBAX
$6.04B-14.7%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$84.97B+8.3%
Axogen logo
AxogenAXGN
$256.26M+128%
CONMED logo
CONMEDCNMD
$1.04B+3.8%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$1.63B+13.9%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$435.19M-5.0%

Other financials

Income statement

See full
Revenue$6.6B+9.4%
Gross profit$4.5B+17.1%
Operating income$1.7B+49.1%
Net income$1.3B+44.3%
EPS (diluted)$3.30+44.1%

Balance sheet

See full
Cash & equivalents$3.4B+42.8%
Total debt$14.2B-15.2%
Total assets$47.9B+3.5%

Cash flow

See full
Operating cash flow$1.3B+13.5%
CapEx$202.0M+10.4%
Free cash flow$1.1B+14.1%

Valuation

See full
Market cap$124.86B-14.4%
Enterprise value$135.66B-15.3%
P/E33.5×-16.5×
P/S4.8×-1.3×

Profitability

See full
Gross margin65%+0.8pp
Operating margin21.4%+6.2pp
Net margin14.4%+2.2pp
FCF margin18.2%+1.3pp

Returns & leverage

See full
Return on equity32.8%—
Debt / equity0.8×—
Current ratio2.2×+0.4×

Where this comes from

Reported directly by Stryker in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: Stryker’s 10-K, filed February 7, 2019. Open the filing →

Filed
Feb 6, 2019, 7:00 PM EST
Fiscal year
FY2018
Accession
0000310764-19-000014

FAQ

What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.